Latanoprost
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 105 (1) , 82-87
- https://doi.org/10.1016/s0161-6420(98)91372-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Melanocytes and Iris ColorArchives of Ophthalmology (1950), 1996
- Melanocytes and Iris ColorArchives of Ophthalmology (1950), 1996
- A Six-month, Randomized, Double-masked Study Comparing Latanoprost with Timolol in Open-angle Glaucoma and Ocular HypertensionOphthalmology, 1996
- Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and GlaucomaOphthalmology, 1996
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol.British Journal of Ophthalmology, 1995
- The Effects on Aqueous Dynamics of PhXA41, a New Prostaglandin F2α Analogue, After Topical Application in Normal and Ocular Hypertensive Human EyesArchives of Ophthalmology (1950), 1993
- Effects of PhXA41, A New Prostaglandin F2α Analog, on Aqueous Humor Dynamics in Human EyesOphthalmology, 1993
- Intraocular Pressure-reducing Effect of PhXA41 in Patients with Increased Eye PressureOphthalmology, 1993
- Intraocular Pressure-reducing Effect of PhXA41 in Ocular HypertensionOphthalmology, 1993
- Maintained Intraocular Pressure Reduction With Once-a-Day Application of a New Prostaglandin F2α Analogue (PhXA41)Archives of Ophthalmology (1950), 1993